메뉴 건너뛰기
Journal of Clinical Psychiatry
Volumn 59, Issue 2, 1998, Pages 47-48
How psychiatrists can build new therapies for impotence
Author keywords

[No Author keywords available]
Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMFEBUTAMONE; AMPHETAMINE; APOMORPHINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; METHYLPHENIDATE; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; NITRIC OXIDE; PHENTOLAMINE; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN; PROSTAGLANDIN E1; SEROTONIN; SEROTONIN 2 RECEPTOR; SILDENAFIL; VASOACTIVE INTESTINAL POLYPEPTIDE;
EID: 0031912850     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v59n0201     Document Type: Short Survey
Times cited : (8)
References (9)
  • 1
    • 0027361003 scopus 로고
    • Pathophysiology of erectile dysfunction
    • Carrier S, Brock G, Kour NW, et al. Pathophysiology of erectile dysfunction. Urology 1993;42:468-481
    • (1993) Urology , vol.42 , pp. 468-481
    • Carrier, S.1    Brock, G.2    Kour, N.W.3
  • 2
    • 0027198755 scopus 로고
    • Impotence
    • NIH Consensus Development Panel on Impotence. Impotence. JAMA 1993;270:83-90
    • (1993) JAMA , vol.270 , pp. 83-90
  • 3
    • 2642670943 scopus 로고    scopus 로고
    • London, England: Martin Dunitz Press
    • Foster MC, Cole M. Impotence. London, England: Martin Dunitz Press; 1996
    • (1996) Impotence
    • Foster, M.C.1    Cole, M.2
  • 5
    • 0029919229 scopus 로고    scopus 로고
    • Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction
    • Linet OI, Ogring FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med 1996;334: 873-877
    • (1996) N Engl J Med , vol.334 , pp. 873-877
    • Linet, O.I.1    Ogring, F.G.2
  • 6
    • 0031605656 scopus 로고    scopus 로고
    • Brain fumes: Yes, we have NO brain gas [BRAINSTORMS]
    • Stahl SM. Brain fumes: yes, we have NO brain gas [BRAINSTORMS]. J Clin Psychiatry 1998;59:6-7
    • (1998) J Clin Psychiatry , vol.59 , pp. 6-7
    • Stahl, S.M.1
  • 7
    • 0030154874 scopus 로고    scopus 로고
    • Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
    • Boolell M. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996;8:47-52
    • (1996) Int J Impot Res , vol.8 , pp. 47-52
    • Boolell, M.1
  • 8
    • 0030438222 scopus 로고    scopus 로고
    • Sildenafil: A novel effective oral therapy for male erectile dysfunction
    • Boolell M. Sildenafil: a novel effective oral therapy for male erectile dysfunction. Br J Urology 1996;78:257-261
    • (1996) Br J Urology , vol.78 , pp. 257-261
    • Boolell, M.1
  • 9
    • 0030572496 scopus 로고    scopus 로고
    • Sildenafil (Viagra): A potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction
    • Terrett M. Sildenafil (Viagra): a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction. Bioorg Med Chem Letters 1996;6:1819-1824
    • (1996) Bioorg Med Chem Letters , vol.6 , pp. 1819-1824
    • Terrett, M.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.